表紙：T細胞療法市場：治療タイプ別、適応症別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測

市場調査レポート

商品コード

1364703

T細胞療法市場：治療タイプ別、適応症別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測

T-Cell Therapy Market, By Therapy Type, By Indication, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

出版日: 2023年10月01日 | 発行: AnalystView Market Insights

| ページ情報: 英文 311 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 3,250 506,545円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは社内利用に限り可能です。PDFの印刷はできません。

PDF (5 User License)

USD 4,650 724,749円

レポートPDFを同一事業所内の5名までがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは社内利用に限り可能です。PDFの印刷は可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 5,650 880,609円

レポートPDFを企業内すべての方がご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは社内利用に限り可能です。PDFの印刷は可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=155.86円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

レポートハイライト

T細胞療法の市場規模は2022年に27億860万米ドルとなり、2023年から2030年にかけてCAGR 34.9%で拡大

T細胞療法市場- 市場力学

疾患治療のための新規治療法開拓への注目の高まりが、T細胞療法市場の成長を牽引すると予想されます。

疾病、特にがんの世界の蔓延が増加するにつれ、より効果的でオーダーメイドの治療法が緊急に求められています。米国国立がん研究所によると、2023年には米国でおよそ200万人ががんと診断されます。そのうち297,790人の女性と2,800人の男性が乳がんと診断されると推定され、乳がんは最も一般的ながんと診断されます。T細胞治療は、特に耐性疾患や再発疾患に苦しむ人々にとって、実行可能な治療オプションとして台頭してきています。T細胞治療の可能性を考慮し、研究開発には莫大な投資がなされています。さらに、新規の生物学的療法の研究が進み、生物学的製剤の供給と安全性が高まっていることも、T細胞療法市場に成長機会をもたらすと期待される要因です。しかし、生命を脅かす重篤な毒性、控えめな抗腫瘍活性、抗原逃避、輸送の制限、腫瘍浸潤の制限などが、市場の成長を制限する要因となっています。

T細胞療法市場-セグメンテーション分析：

世界のT細胞療法市場は、治療タイプ、適応症、地域によって区分されます。

市場は治療タイプに基づいて3つのカテゴリーに分けられる：CAR T細胞療法、細胞受容体（TCR）ベース、腫瘍浸潤リンパ球（TIL）ベースです。CAR T細胞療法分野が市場成長を支配すると予想されます。CAR-T療法はT細胞療法の一種で、がん細胞を特異的に標的とする受容体（CAR）を発現するようにT細胞が遺伝子操作されます。

同市場は、適応症によって2つのカテゴリーに分けられる：血液悪性腫瘍、固形腫瘍、その他です。市場成長を支配しているのは血液悪性腫瘍です。CAR-T細胞免疫療法は、急性リンパ芽球性白血病（ALL）、多発性骨髄腫（MM）、慢性リンパ性白血病（CLL）、急性骨髄性白血病（AML）、ホジキンリンパ腫（HL）、非ホジキンリンパ腫（NHL）などの血液悪性腫瘍を患う患者に対する重要な治療選択肢として広く認知されています。

T細胞療法市場-地理的洞察

T細胞療法市場は、北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広く分布しています。これらの地域は、ビジネスを展開する国によってさらに分けられます。北米は、養子縁組療法の開発に注力する製薬企業の増加により、市場の成長を支配すると予想されています。北米、特に米国には、無数のバイオテクノロジー新興企業、一流の研究機関、世界最大級の製薬企業が集まっています。これらの組織は、養子T細胞療法のような新規治療薬に積極的に投資し、その普及に努めています。例えば、がん患者に対するプログラム細胞免疫療法の開発を専門とする臨床段階のバイオ医薬品企業であるフェイト・セラピューティクス社は、第64回米国血液学会（ASH）年次総会・展示会において、条件付け化学療法を行わずに既製の細胞ベースのがん免疫療法を投与できるように設計されたいくつかの新規戦略に関する前臨床データを発表しました。

製薬業界は引き続き技術革新の温床であり、新たな治療パラダイムの進化やアンメットニーズの深刻さに加え、ファーマコゲノミクス、デジタル治療学、人工知能などの技術の重要性の高まりが、その活動を後押ししています。さらに、キメラ抗原受容体（CAR）-T細胞療法やT細胞受容体（TCR）-ベース、腫瘍浸潤リンパ球（TIL）-ベースのようなT細胞療法に関連する製品承認の増加により、欧州とアジア太平洋はT細胞療法市場の大幅な成長を促進すると予想されます。

T細胞療法市場-競合情勢：

複数の新規参入企業がT細胞療法分野の技術革新を推進しています。次世代CAR-T療法に注力している企業もあれば、別の細胞タイプやより安全な設計、コスト削減戦略を研究している企業もあります。また、新しいCAR-T療法の堅実な開発は、企業による知的財産権の積極的な活用と、多額の研究開発投資によって特徴付けられます。メーカー各社は、CAR-T技術の特許と臨床の状況を展示し、現在の臨床試験環境、最先端のCAR関連発明、主な関係者、そして新技術を生み出すための相互作用について解説しています。さらに、T細胞治療は当初、北米や欧州の一部に集中していました。アジア太平洋、ラテンアメリカ、中東での薬事承認は大きな新市場を開く可能性があり、企業が手を広げることで需要が高まる。

イントロダクション
北米
- 概要
- 北米の主要メーカー
- 米国
- カナダ
欧州
- 概要
- 欧州の主要メーカー
- ドイツ
- イタリア
- 英国
- フランス
- ロシア
- オランダ
- スウェーデン
- ポーランド
- その他
アジア太平洋（APAC）
- 概要
- アジア太平洋地域の主要メーカー
- インド
- 中国
- 日本
- 韓国
- オーストラリア
- タイ
- インドネシア
- フィリピン
- その他
ラテンアメリカ
- 概要
- ラテンアメリカの主要メーカー
- ブラジル
- メキシコ
- アルゼンチン
- コロンビア
- その他
中東とアフリカ
- 概要
- 中東およびアフリカの主要メーカー
- サウジアラビア
- アラブ首長国連邦
- イスラエル
- トルコ
- アルジェリア
- エジプト
- その他

第10章主要ベンダー分析-T細胞治療産業

競合ダッシュボード
企業プロファイル
- Novartis AG
- Merck KGaA
- Gilead Sciences Inc.
- TCR2 Therapeutics Inc
- Bluebird Bio Inc.
- Sorrento Therapeutics
- Fate Therapeutics
- Pfizer Inc.
- Amgen
- Celgene Corporation

第11章アナリストの全方位展望

図表

List of Tables

TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE T-Cell Therapy Market: Therapy Type Snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Therapy Type
TABLE Global T-Cell Therapy Market, by Therapy Type 2018-2030 (USD Million)
TABLE T-Cell Therapy Market: Indication Snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Indication
TABLE Global T-Cell Therapy Market, by Indication 2018-2030 (USD Million)
TABLE T-Cell Therapy Market: Regional snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global T-Cell Therapy Market, by Region 2018-2030 (USD Million)
TABLE North America T-Cell Therapy Market, by Country, 2018-2030 (USD Million)
TABLE North America T-Cell Therapy Market, by Therapy Type, 2018-2030 (USD Million)
TABLE North America T-Cell Therapy Market, by Indication, 2018-2030 (USD Million)
TABLE Europe T-Cell Therapy Market, by Country, 2018-2030 (USD Million)
TABLE Europe T-Cell Therapy Market, by Therapy Type, 2018-2030 (USD Million)
TABLE Europe T-Cell Therapy Market, by Indication, 2018-2030 (USD Million)
TABLE Asia Pacific T-Cell Therapy Market, by Country, 2018-2030 (USD Million)
TABLE Asia Pacific T-Cell Therapy Market, by Therapy Type, 2018-2030 (USD Million)
TABLE Asia Pacific T-Cell Therapy Market, by Indication, 2018-2030 (USD Million)
TABLE Latin America T-Cell Therapy Market, by Country, 2018-2030 (USD Million)
TABLE Latin America T-Cell Therapy Market, by Therapy Type, 2018-2030 (USD Million)
TABLE Latin America T-Cell Therapy Market, by Indication, 2018-2030 (USD Million)
TABLE Middle East and Africa T-Cell Therapy Market, by Country, 2018-2030 (USD Million)
TABLE Middle East and Africa T-Cell Therapy Market, by Therapy Type, 2018-2030 (USD Million)
TABLE Middle East and Africa T-Cell Therapy Market, by Indication, 2018-2030 (USD Million)

List of Figures

FIGURE T-Cell Therapy Market Segmentation
FIGURE Market research methodology
FIGURE Value chain analysis
FIGURE Porter's Five Forces Analysis
FIGURE Market Attractiveness Analysis
FIGURE COVID-19 Impact Analysis
FIGURE Pre & Post COVID-19 Impact Comparision Study
FIGURE Competitive Landscape; Key company market share analysis, 2022
FIGURE Therapy Type segment market share analysis, 2022 & 2030
FIGURE Therapy Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Indication segment market share analysis, 2022 & 2030
FIGURE Indication segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Regional segment market share analysis, 2022 & 2030
FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE North America T-Cell Therapy Market share and leading players, 2022
FIGURE Europe T-Cell Therapy Market share and leading players, 2022
FIGURE Asia Pacific T-Cell Therapy Market share and leading players, 2022
FIGURE Latin America T-Cell Therapy Market share and leading players, 2022
FIGURE Middle East and Africa T-Cell Therapy Market share and leading players, 2022
FIGURE North America market share analysis by country, 2022
FIGURE U.S. T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Canada T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Europe T-Cell Therapy Market share analysis by country, 2022
FIGURE Germany T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Spain T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Italy T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE France T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE UK T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Russia T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Netherlands T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Sweden T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Poland T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Rest of the Europe T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Asia Pacific T-Cell Therapy Market share analysis by country, 2022
FIGURE India T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE China T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Japan T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE South Korea T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Australia T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Thailand T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Indonesia T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Phillipines T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Rest of APAC T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Latin America T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Latin America T-Cell Therapy Market share analysis by country, 2022
FIGURE Brazil T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Mexico T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Argentina T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Colombia T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Rest of LATAM T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Middle East and Africa T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Middle East and Africa T-Cell Therapy Market share analysis by country, 2022
FIGURE Saudi Arabia T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE United Arab Emirates T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Israel T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Turkey T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Algeria T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Egypt T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Rest of MEA T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)

Product Code: ANV1751

REPORT HIGHLIGHT

T-Cell Therapy Market size was valued at USD 2,708.6 Million in 2022, expanding at a CAGR of 34.9% from 2023 to 2030.

T-cell therapy is a form of immunotherapy in which T-cells, a type of white blood cell, are used to treat specific disorders, most notably cancer. There are two main types of T-cell transfer therapy tumor-infiltrating lymphocytes (or TIL) therapy and CAR T-cell therapy. T-cell transfer therapy was initially investigated for the treatment of metastatic melanoma since melanomas frequently cause a robust immune response and have a high number of TILs. TIL treatment has been shown to be successful in some cases of melanoma and has achieved encouraging results in other cancers such as cervical squamous cell carcinoma and cholangiocarcinoma. However, T-cell therapy is a key advancement in cancer treatment. Conversely, like many medicines, it comes with both enormous promise and significant challenges. There is continuing research to increase the efficacy, safety, and accessibility of these medicines.

T-Cell Therapy Market- Market Dynamics

The rising focus on Developing new therapies for the treatment of diseases is expected to drive the growth of the T-cell therapy market.

As the global prevalence of diseases, particularly cancer, rises, there is an urgent requirement for more effective and tailored therapies. According to the National Cancer Institute, in 2023, roughly 2.0 million people will be diagnosed with cancer in the United States. An estimated 297,790 women and 2,800 men will be diagnosed with breast cancer, which makes it the most common cancer diagnosis. T-cell treatments are emerging as a viable treatment option, particularly for individuals suffering from resistant or recurrent diseases. Given the potential of T-cell treatments, enormous investment has been made in research and development. Furthermore, advancing research on novel biotherapies and increasing the supply and safety of biologics are the factors that are expected to provide growth opportunities for the T-cell therapy market. However, severe life-threatening toxicities, modest anti-tumor activity, antigen escape, restricted trafficking, and limited tumor infiltration are the factors that restrict the growth of the market.

T-Cell Therapy Market- Key Insights

As per the analysis shared by our research analyst, the global T-Cell Therapy market is estimated to grow annually at a CAGR of around 34.9% over the forecast period (2023-2030)

The T-cell therapy industry is expected to grow at a rapid pace due to the rising cancer burden and increased research and development to create T-cell therapy.

Based on Therapy type segmentation, CAR T-cell Therapy was predicted to show maximum market share in the year 2022

Based on Indication segmentation, Hematologic Malignancies was the leading type in 2022

On the basis of region, North America was the leading revenue generator in 2022

T-Cell Therapy Market- Segmentation Analysis:

The Global T-Cell Therapy Market is segmented on the basis of Therapy Type, Indication, and Region.

The market is divided into three categories based on Therapy type: CAR T-cell Therapy, Cell Receptor (TCR)-based, and Tumor Infiltrating Lymphocytes (TIL)-based. CAR T-cell Therapy segment is expected to dominate the market growth. CAR-T therapy is a type of T-cell therapy in which T-cells are genetically engineered to express a receptor (the CAR) that can specifically target cancer cells.

The market is divided into two categories based on Indication: Hematologic Malignancies, Solid Tumors, and Others. Hematologic Malignancies dominate the market growth. CAR-T-cell immunotherapy is widely recognized as an important treatment option for patients suffering from hematological malignancies such as acute lymphoblastic leukemia (ALL), multiple myeloma (MM), chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), Hodgkin lymphoma (HL), and non-Hodgkin lymphoma (NHL).

T-Cell Therapy Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the market, due to the increasing number of pharmaceutical companies focusing on developing adoptive therapies, North America, particularly the United States, is host to a myriad of biotech startups, prestigious research institutions, and some of the world's largest pharmaceutical companies. These organizations actively invest in and push the margins of novel therapeutics, such as adoptive T-cell therapy. For example, Fate Therapeutics, Inc, a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for patients with cancer, presented preclinical data of several novel strategies designed to enable the administration of off-the-shelf cell-based cancer immunotherapies without conditioning chemotherapy at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition.

The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and the gravity of unmet need, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence. Furthermore, Europe and Asia Pacific are expected to propel significant growth in T-cell therapy Market, due to the Growing Product Approvals Associated with T-cell therapies like Chimeric antigen receptor (CAR)-T cell therapy and T Cell Receptor (TCR)-based and Tumor Infiltrating Lymphocytes (TIL)-based.

T-Cell Therapy Market- Competitive Landscape:

Several new market players are driving innovation in the field of T-cell therapy. Some are concentrating on next-generation CAR-T therapy, while others are investigating alternate cell types, safer designs, or cost-cutting strategies. Also, the robust development of new CAR-T therapies is characterized by the active use of intellectual property rights by firms, as well as substantial R&D investments. Manufacturers exhibit CAR-T technologies' patent and clinical landscape, covering the current clinical trial environment, cutting-edge CAR-related inventions, the main actors, and how they interact with one another to generate new technologies. Furthermore, T-cell treatments were initially more focused in regions such as North America and parts of Europe. Regulatory approvals in Asia-Pacific, Latin America, and the Middle East can open up large new markets, raising demand as corporations expand their reach.

Recent Developments:

In October 2019, Merck, a leading science and technology company, nowadays announced it had acquired FloDesign Sonics, of Wilbraham, Massachusetts, USA, developer of a unique acoustic cell processing platform for the industrialization of cell and gene therapy manufacturing. Financial details were not disclosed.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL T-CELL THERAPY MARKET KEY PLAYERS

Novartis AG
Merck KGaA
Gilead Sciences Inc.
TCR2 Therapeutics Inc
Bluebird Bio Inc.
Sorrento Therapeutics
Fate Therapeutics
Pfizer Inc.
Amgen
Celgene Corporation

GLOBAL T-CELL THERAPY MARKET, BY THERAPY TYPE

CAR T-cell Therapy
T Cell Receptor (TCR)-based
Tumor Infiltrating Lymphocytes (TIL)-based

GLOBAL T-CELL THERAPY MARKET, BY INDICATION

Hematologic Malignancies
Solid Tumors
Others

GLOBAL T-CELL THERAPY MARKET, BY REGION

North America

The U.S.
Canada

Europe

Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe

Asia Pacific

India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC

Latin America

Brazil
Mexico
Argentina
Colombia
Rest of LATAM

The Middle East and Africa

Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. T-Cell Therapy Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. T-Cell Therapy Market Snippet by Therapy Type
- 2.1.2. T-Cell Therapy Market Snippet by Indication
- 2.1.3. T-Cell Therapy Market Snippet by Country
- 2.1.4. T-Cell Therapy Market Snippet by Region
2.2. Competitive Insights

3. T-Cell Therapy Key Market Trends

3.1. T-Cell Therapy Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. T-Cell Therapy Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. T-Cell Therapy Market Opportunities
3.4. T-Cell Therapy Market Future Trends

4. T-Cell Therapy Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. T-Cell Therapy Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. T-Cell Therapy Market Landscape

6.1. T-Cell Therapy Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. T-Cell Therapy Market - By Therapy Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Therapy Type, 2022 & 2030 (%)
- 7.1.2. CAR T-cell Therapy
- 7.1.3. T Cell Receptor (TCR)-based
- 7.1.4. Tumor Infiltrating Lymphocytes (TIL)-based

8. T-Cell Therapy Market - By Indication

8.1. Overview
- 8.1.1. Segment Share Analysis, By Indication, 2022 & 2030 (%)
- 8.1.2. Hematologic Malignancies
- 8.1.3. Solid Tumors
- 8.1.4. Others

9. T-Cell Therapy Market- By Geography

9.1. Introduction
- 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
9.2. North America
- 9.2.1. Overview
- 9.2.2. T-Cell Therapy Key Manufacturers in North America
- 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.2.4. North America Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.2.5. North America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.2.6. U.S.
  - 9.2.6.1. Overview
  - 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.2.6.3. U.S. Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 9.2.6.4. U.S. Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.2.7. Canada
  - 9.2.7.1. Overview
  - 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.2.7.3. Canada Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 9.2.7.4. Canada Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.3. Europe
- 9.3.1. Overview
- 9.3.2. T-Cell Therapy Key Manufacturers in Europe
- 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.3.4. Europe Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.3.5. Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.3.6. Germany
  - 9.3.6.1. Overview
  - 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.6.3. Germany Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 9.3.6.4. Germany Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.3.7. Italy
  - 9.3.7.1. Overview
  - 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.7.3. Italy Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 9.3.7.4. Italy Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.3.8. United Kingdom
  - 9.3.8.1. Overview
  - 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.8.3. United Kingdom Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 9.3.8.4. United Kingdom Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.3.9. France
  - 9.3.9.1. Overview
  - 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.9.3. France Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 9.3.9.4. France Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.3.10. Russia
  - 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.10.2. Russia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 9.3.10.3. Russia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.3.11. Netherlands
  - 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.11.2. Netherlands Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 9.3.11.3. Netherlands Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.3.12. Sweden
  - 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.12.2. Sweden Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 9.3.12.3. Sweden Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.3.13. Poland
  - 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.13.2. Poland Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 9.3.13.3. Poland Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.3.14. Rest of Europe
  - 9.3.14.1. Overview
  - 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.14.3. Rest of the Europe Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 9.3.14.4. Rest of the Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.4. Asia Pacific (APAC)
- 9.4.1. Overview
- 9.4.2. T-Cell Therapy Key Manufacturers in Asia Pacific
- 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.4.4. Asia Pacific Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.4.5. Asia Pacific Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.4.6. India
  - 9.4.6.1. Overview
  - 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.6.3. India Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 9.4.6.4. India Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.4.7. China
  - 9.4.7.1. Overview
  - 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.7.3. China Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 9.4.7.4. China Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.4.8. Japan
  - 9.4.8.1. Overview
  - 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.8.3. Japan Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 9.4.8.4. Japan Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.4.9. South Korea
  - 9.4.9.1. Overview
  - 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.9.3. South Korea Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 9.4.9.4. South Korea Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.4.10. Australia
  - 9.4.10.1. Overview
  - 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.10.3. Australia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 9.4.10.4. Australia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.4.11. Thailand
  - 9.4.11.1. Overview
  - 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.11.3. Thailand Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 9.4.11.4. Thailand Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.4.12. Indonesia
  - 9.4.12.1. Overview
  - 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.12.3. Indonesia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 9.4.12.4. Indonesia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.4.13. Philippines
  - 9.4.13.1. Overview
  - 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.13.3. Philippines Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 9.4.13.4. Philippines Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.4.14. Rest of APAC
  - 9.4.14.1. Overview
  - 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.14.3. Rest of APAC Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 9.4.14.4. Rest of APAC Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.5. Latin America
- 9.5.1. Overview
- 9.5.2. T-Cell Therapy Key Manufacturers in Latin America
- 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.5.4. Latin America Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.5.5. Latin America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.5.6. Brazil
  - 9.5.6.1. Overview
  - 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.5.6.3. Brazil Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 9.5.6.4. Brazil Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.5.7. Mexico
  - 9.5.7.1. Overview
  - 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.5.7.3. Mexico Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 9.5.7.4. Mexico Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.5.8. Argentina
  - 9.5.8.1. Overview
  - 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.5.8.3. Argentina Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 9.5.8.4. Argentina Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.5.9. Colombia
  - 9.5.9.1. Overview
  - 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.5.9.3. Colombia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 9.5.9.4. Colombia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.5.10. Rest of LATAM
  - 9.5.10.1. Overview
  - 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.5.10.3. Rest of LATAM Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 9.5.10.4. Rest of LATAM Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.6. Middle East and Africa
- 9.6.1. Overview
- 9.6.2. T-Cell Therapy Key Manufacturers in Middle East and Africa
- 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.6.4. Middle East and Africa Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 9.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.6.6. Saudi Arabia
  - 9.6.6.1. Overview
  - 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.6.6.3. Saudi Arabia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 9.6.6.4. Saudi Arabia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.6.7. United Arab Emirates
  - 9.6.7.1. Overview
  - 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.6.7.3. United Arab Emirates Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 9.6.7.4. United Arab Emirates Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.6.8. Israel
  - 9.6.8.1. Overview
  - 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.6.8.3. Israel Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 9.6.8.4. Israel Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.6.9. Turkey
  - 9.6.9.1. Overview
  - 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.6.9.3. Turkey Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 9.6.9.4. Turkey Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.6.10. Algeria
  - 9.6.10.1. Overview
  - 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.6.10.3. Algeria Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 9.6.10.4. Algeria Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.6.11. Egypt
  - 9.6.11.1. Overview
  - 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.6.11.3. Egypt Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 9.6.11.4. Egypt Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
- 9.6.12. Rest of MEA
  - 9.6.12.1. Overview
  - 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.6.12.3. Rest of MEA Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 9.6.12.4. Rest of MEA Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- T-Cell Therapy Industry

10.1. Competitive Dashboard
10.2. Company Profiles
- 10.2.1. Novartis AG
- 10.2.2. Merck KGaA
- 10.2.3. Gilead Sciences Inc.
- 10.2.4. TCR2 Therapeutics Inc
- 10.2.5. Bluebird Bio Inc.
- 10.2.6. Sorrento Therapeutics
- 10.2.7. Fate Therapeutics
- 10.2.8. Pfizer Inc.
- 10.2.9. Amgen
- 10.2.10. Celgene Corporation

11. 360 Degree Analyst View

12. Appendix

12.1. Research Methodology
12.2. References
12.3. Abbreviations
12.4. Disclaimer
12.5. Contact Us